Scott Jordan will be speaking at the 3rd Oncology Partnering & Deal-Making conference July 7-8, 2014 at the Hyatt Regency in Boston, MA, presented by Global Technology Community.

This conference is part of the larger Novel Cancer Therapeutics Summit, which also includes one additional co-located conference, 5th Cancer Targets & Therapeutics.

This event is a partnership and business development conference that provides an opportunity to network with high-level executives from top pharma and various biotech/pharmaceutical companies, as well as explore potential collaborations and learn about relevant issues in oncology that will affect the industry. Experts in the field of oncology will present on the latest discoveries, novel technologies, business development trends, markets, partnership opportunities, alliance management, value maximization vs. capital efficiency, and the rebirth of IPOs.

Sessions include 1) Investments, Partnerships & Acquisitions: Trends & Recent Deals; 2) Innovative Partnering & Deal-Making (Panel Discussion); 3) IPO: The Rebirth of Access to Public Capital; 4) Value Maximization vs. Capital Efficiency (Panel Discussion); 5) Advances & Technologies in Oncology; and 6) Novel Players in Oncology.

Register for the event here.

You can find a list of speakers here, and more details about the conference here.